IP Library Granted Patent US 10,682,251
Granted Patent B2
US 10,682,251 · App. 15/814,274 · Granted Jun 16, 2020

Reduced-pressure systems, devices, and methods for treating a tissue site that includes a fistula

Inventors: Colin John Hall (Poole, GB); Richard Paul Mormino (San Antonio, TX)
Assignee: KCI Licensing, Inc.
A61F5/445A61M1/0088A61F2005/4455A61M27/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,682,251
App. No.
15/814,274
Granted
Jun 16, 2020
Kind
B2
Abstract

Systems, methods, and devices are disclosed that involve a fistula-isolating device for use when reduced pressure is applied to a wound bed having a fistula. In one instance, the fistula-isolating device includes an adjustable passageway member and a perimeter member that contracts under reduced pressure and that automatically accommodates wound beds of different heights. In another instance, the fistula-isolating device involves a body shaped as a frustro-conical body that is readily sized for different depth wound beds. Other systems, methods, and devices are presented.

Claims (19)

1. A system for providing reduced pressure treatment to a wound bed that includes a fistula, the system comprising:

a fistula-isolating device for isolating a fistula in the wound bed undergoing reduced-pressure treatment, the fistula-isolating device comprising:

an adjustable passageway member, wherein the adjustable passageway member is configured to move between a retracted position and an extended position and is substantially fluid impermeable, and

a perimeter member comprising a fluid permeable material, the perimeter member positioned substantially around an exterior perimeter of the adjustable passageway member;

a distribution manifold having a fistula aperture for receiving the fistula-isolating device;

a sealing member for covering the fistula-isolating device and the distribution manifold to create a sealed space over at least a portion of the wound bed, wherein the sealing member has an ostomy-interface aperture;

a reduced-pressure source for supplying a reduced pressure to the sealed space; and

an ostomy appliance configured to be in fluid communication with the adjustable passageway member.

2. The system of claim 1 , wherein the distribution manifold has an initial height h d1 when not subjected to reduced pressure, the fistula-isolating device has an initial height h F1 when not subjected to reduced pressure, and h d1 is substantially equal to h F1 .

3. The system of claim 1 , wherein the distribution manifold has a height h d2 when the sealed space is subjected to reduce pressure in a first therapeutic pressure range, the fistula-isolating device has a height h F2 when the sealed space is subjected to reduce pressure in the first therapeutic pressure range, and h d2 is substantially equal to h F2 .

4. A system for providing reduced pressure treatment to a wound bed that includes a fistula, the system comprising:

a fistula-isolating device for isolating a fistula in the wound bed undergoing reduced-pressure treatment, the fistula-isolating device comprising:

an adjustable passageway member, wherein the adjustable passageway member is configured to move between a retracted position and an extended position and is substantially fluid impermeable, and

a perimeter member positioned substantially around an exterior perimeter of the adjustable passageway member, wherein the perimeter member is configured to bias the adjustable passageway member towards the extended position;

a distribution manifold having a fistula aperture for receiving the fistula-isolating device;

a sealing member for covering the fistula-isolating device and the distribution manifold to create a sealed space over at least a portion of the wound bed, wherein the sealing member has an ostomy-interface aperture; and

a reduced-pressure source for supplying a reduced pressure to the sealed space.

5. The system of claim 4 , wherein the distribution manifold has an initial height h d1 when not subjected to reduced pressure, the fistula-isolating device has an initial height h F1 when not subjected to reduced pressure, and h d1 is substantially equal to h F1 .

6. The system of claim 4 , wherein the distribution manifold has a height h d2 when the sealed space is subjected to reduce pressure in a first therapeutic pressure range, the fistula-isolating device has a height h F2 when the sealed space is subjected to reduce pressure in the first therapeutic pressure range, and h d2 is substantially equal to h F2 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2020
From: HALL, COLIN JOHN; MORMINO, RICHARD PAUL
To: KCI LICENSING, INC.
Reel/Frame 051712/0866 →
Continuity (4)
Division 14268720 · May 2, 2014
Division 13253841 · Oct 5, 2011
Provisional Application 61394999 · Oct 20, 2010
Related Publication 20180125698A1 · May 10, 2018